Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
NREP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
LOC100653296 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
ZBTB46 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ARFGAP2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NR3C1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TMEM116 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC100996693 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
UBA6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MIR6789 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MID1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PRRC2B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FLJ30064 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
WSB1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IRGC - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NR2F6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ADD3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ESD - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on